Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;70(4):635-640.
doi: 10.1136/gutjnl-2020-324000. Epub 2021 Jan 20.

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Corey A Siegel  1 , Gil Y Melmed  2 , Dermot Pb McGovern  2 , Victoria Rai  3   4 , Florian Krammer  5 , David T Rubin  3 , Maria T Abreu  6 , Marla C Dubinsky  7 ; International Organization for the Study of Inflammatory Bowel Disease (IOIBD); International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)
Collaborators, Affiliations

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Corey A Siegel et al. Gut. 2021 Apr.
No abstract available

Keywords: COVID-19; IBD; crohn's disease; immune response; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CS: Consultant/Advisory Board for Abbvie, Amgen, BMS, Lilly, Janssen, Pfizer, Prometheus, Takeda ; Speaker for CME activities for Abbvie, Celgene, Janssen, Pfizer, Takeda; Grant support from Abbvie, Janssen, Pfizer, Takeda. GYM: Consultant for Abbvie, Boehringer-Ingelheim, Bristol Meyers Squibb, Celgene, Genentech/Roche, Entasis, Janssen Pharmaceuticals, Merck, Medtronic, Nephroceuticals, Pfizer, Samsung Bioepis, Takeda, Techlab. DPBM: Consultant and Shareholder for Prometheus Biosciences; Consultant for Gilead Sciences, Boehringer-Ingelheim, Pfizer, Bridge Biotherapeutics, Qu Biologics, Prometheus Biosciences, Takeda, Palatin Technologies; Grant support from Janssen. VR: nothing to disclose. FK: Consultant fees: Curevac, Pfizer, Merck, Seqirus, Avimex; Grant support: GSK, Pfizer, Dynavax, NIAID, DoD, BMGF, NCI. DTR: Consultant for Abbvie, Abgenomics, Biomica, Bristol-Myers Squibb, Celgene Corp/Syneos, Dizal Pharmaceuticals, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, GlaxoSmithKline Services, InDex Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Pfizer, Prometheus Laboratories, Reistone, Takeda, and Techlab. MTA: Consultant fees: Boehringer Ingelheim Pharmaceuticals, Gilead, Janssen, Abbvie, Eli Lilly and Landos Biopharma; Lecturer for Imedex, Focus Medical Communications and Cornerstones Health; Funded investigator-initiated projects: Pfizer, Prometheus Laboratories and Takeda Pharmaceuticals. MCD: Consultant fees: Abbvie, Arena, BMS, Celgene, Genentech, Janssen, Pfizer, Prometheus biosciences, Takeda, Target RWE; Grant support: Abbvie, Janssen, Pfizer

References

    1. . Available: https://coronavirus.jhu.edu/map.html [Accessed on December 20, 2020].
    1. Wrapp D, Wang N, Corbett KS, et al. Cryo-Em structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367:1260–3. 10.1126/science.abb2507 - DOI - PMC - PubMed
    1. Wrapp D, De Vlieger D, Corbett KS, et al. Structural basis for potent neutralization of Betacoronaviruses by single-domain camelid antibodies. Cell 2020;181:1004–15. 10.1016/j.cell.2020.04.031 - DOI - PMC - PubMed
    1. Corbett KS, Edwards DK, Leist SR, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 2020;586:567–71. 10.1038/s41586-020-2622-0 - DOI - PMC - PubMed
    1. Krammer F. SARS-CoV-2 vaccines in development. Nature 2020;586:516–27. 10.1038/s41586-020-2798-3 - DOI - PubMed

Publication types

MeSH terms